N/A
Completed N=7,052
Blood Glucose Monitoring in Electronic Health Records
Source: ClinicalTrials.gov NCT03542487 ↗Enrolled (actual)
7,052
Serious AEs
—
Results posted
Sep 2024
Primary outcomePrimary: Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin — 4; 27; 44; 43 Participants
Summary
This multi-site randomized tral aims to test methods of increasing adoption and integration of blood glucose monitoring into electronic medical records, and to measure the impact of wide-scale adoption on health status of patients with diabetes. To investigate determinants of adoption, the research will combine and test doctor and patient focused approaches to encouraging patient use of blood glucose flow sheets through the online patient portal, MyChart. Adoption will be measured on both the extensive and intensive margin: the number of patients who enter data into the flowsheets at all during the study period, and the mean number of entries per patient during the study period. Conditional on statistically significant increases in adoption, the study will examine corresponding intent-to-treat effects on patient A1c, and consider other indicators of possible mechanisms through which A1c improves or does not improve.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin |
4; 15; 17; 20; 30 | — |
| PRIMARY Participant A1c Test Results (as Percent A1c) at 26 Weeks |
7.179; 7.327; 7.110; 7.227; 7.227 | — |
| SECONDARY Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin |
4; 15; 17; 20; 30 | — |
| SECONDARY Number of Days Participant Used Flowsheet, Intensive |
0.011; 0.501; 0.350; 0.663; 0.691; 0.009 | — |
| SECONDARY Count of Participants With an Open Physician Order for Electronic Glucose Flowsheet |
5; 466; 589; 554; 573; 6 | — |
| SECONDARY Number of Days Since Last HbA1c Test |
196.369; 196.828; 205.607; 192.341; 210.748; 196.434 | — |
| SECONDARY Participant A1c Test Results (as Percent A1c) at 14 Weeks |
7.196; 7.276; 7.123; 7.183; 7.197 | — |
| SECONDARY Count of Participants With Improvement of HbA1c Test Results |
666; 155; 158; 160; 147; 961 | — |
| SECONDARY Count of Participants With Percent A1c Below Benchmark of 7 |
1846; 388; 453; 442; 458; 1799 | — |
| SECONDARY Total Secure Messages Sent by Participant |
1.385; 1.407; 1.528; 1.434; 1.571; 1.128 | — |
| SECONDARY Total Secure Messages Sent by Patient to Primary Care Provider |
— | — |
| SECONDARY Total Secure Messages Sent by PCP to Patient |
— | — |
| SECONDARY Total Number of Participant Phone Appointments |
0.792; 0.827; 0.789; 0.849; 0.765; 1.442 | — |
| SECONDARY Total Number of Participant In-person Appointments |
1.275; 1.314; 1.251; 1.109; 1.191; 2.326 | — |
| SECONDARY Count of Participants With Changes to Active Medication List |
742; 135; 133; 141; 140; 1132 | — |
| SECONDARY Prescription Orders |
5.111; 5.912; 4.488; 4.733; 4.259; 9.296 | — |
| SECONDARY Flowsheet Entry Values (Descriptive) |
— | — |
Eligibility Criteria
Inclusion Criteria
- Adult patients of Inova physicians at primary care sites other than Ashburn II Primary Care, Lake Ridge Primary Care and Springfield Primary Care
- Current diabetes mellitus diagnosis
- Active MyChart account at time of treatment administration
Exclusion Criteria
- Patients who participating physicians identify as pregnant
- Patients who participating physicians identify as having contraindications for tracking of blood glucose
Data sourced from ClinicalTrials.gov (NCT03542487). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.